MedTrace Logo

Comparison of Perioperative Opioid Consumption Following Pectoral Nerve Block for Breast Cancer Surgery

NCT02741232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-03-20

No results posted yet for this study

Summary

In this study, the investigators will compare the intraoperative opioid consumption for patients undergoing breast cancer surgery. The patients will be divided in two groups, the first one will receive a pectoral nerve block right after induction of anesthesia and the second one, the control group, will not receive the pectoral block. Our hypothesis is that the pectoral nerve block reduces the opioid consumption during the surgery.

Conditions

  • Nerve Block
  • Mastectomy

Interventions

DRUG

Lidocaine 1% with epinephrine 1/400000

OTHER

sham block

Sponsors & Collaborators

  • Maisonneuve-Rosemont Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-08-30
Completion
2017-09-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02741232 on ClinicalTrials.gov